Strs Ohio raised its holdings in shares of Colgate-Palmolive (NYSE:CL) by 1.9% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 415,958 shares of the company’s stock after buying an additional 7,713 shares during the quarter. Strs Ohio’s holdings in Colgate-Palmolive were worth $28,509,000 as of its most recent SEC filing.
Other institutional investors have also added to or reduced their stakes in the company. Ffcm LLC grew its holdings in shares of Colgate-Palmolive by 5.6% during the fourth quarter. Ffcm LLC now owns 63,206 shares of the company’s stock worth $3,762,000 after buying an additional 3,325 shares in the last quarter. Nachman Norwood & Parrott Inc grew its holdings in shares of Colgate-Palmolive by 1.9% during the first quarter. Nachman Norwood & Parrott Inc now owns 11,101 shares of the company’s stock worth $761,000 after buying an additional 209 shares in the last quarter. River & Mercantile Asset Management LLP purchased a new stake in shares of Colgate-Palmolive during the fourth quarter worth $7,765,000. ST Germain D J Co. Inc. grew its holdings in shares of Colgate-Palmolive by 14.3% during the fourth quarter. ST Germain D J Co. Inc. now owns 16,530 shares of the company’s stock worth $984,000 after buying an additional 2,065 shares in the last quarter. Finally, Psagot Investment House Ltd. grew its holdings in shares of Colgate-Palmolive by 38.9% during the fourth quarter. Psagot Investment House Ltd. now owns 4,073 shares of the company’s stock worth $242,000 after buying an additional 1,140 shares in the last quarter. 76.27% of the stock is owned by institutional investors and hedge funds.
In other Colgate-Palmolive news, CEO Ian M. Cook sold 16,000 shares of the company’s stock in a transaction dated Friday, March 15th. The shares were sold at an average price of $66.72, for a total value of $1,067,520.00. Following the transaction, the chief executive officer now owns 1,146,793 shares of the company’s stock, valued at $76,514,028.96. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Ian M. Cook sold 17,750 shares of the company’s stock in a transaction dated Monday, April 15th. The shares were sold at an average price of $68.61, for a total transaction of $1,217,827.50. Following the completion of the transaction, the insider now directly owns 1,111,293 shares in the company, valued at approximately $76,245,812.73. The disclosure for this sale can be found here. Insiders sold 103,200 shares of company stock worth $6,900,449 in the last ninety days. 1.14% of the stock is currently owned by corporate insiders.
Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, January 25th. The company reported $0.74 EPS for the quarter, beating the Zacks’ consensus estimate of $0.73 by $0.01. Colgate-Palmolive had a net margin of 15.44% and a return on equity of 25,268.29%. The company had revenue of $3.81 billion for the quarter, compared to analysts’ expectations of $3.78 billion. During the same quarter in the prior year, the company posted $0.75 earnings per share. Colgate-Palmolive’s revenue for the quarter was down 2.1% compared to the same quarter last year. As a group, analysts forecast that Colgate-Palmolive will post 2.83 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be given a $0.43 dividend. The ex-dividend date of this dividend is Wednesday, April 17th. This represents a $1.72 dividend on an annualized basis and a yield of 2.48%. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.42. Colgate-Palmolive’s dividend payout ratio is presently 57.91%.
A number of equities research analysts have recently issued reports on the stock. Zacks Investment Research lowered shares of Colgate-Palmolive from a “buy” rating to a “sell” rating in a report on Monday, April 15th. Citigroup set a $68.00 price target on shares of Colgate-Palmolive and gave the company a “hold” rating in a research report on Tuesday, March 19th. UBS Group boosted their price target on shares of Colgate-Palmolive from $71.00 to $75.00 and gave the company a “buy” rating in a research report on Friday, March 29th. Macquarie set a $57.00 price target on shares of Colgate-Palmolive and gave the company a “hold” rating in a research report on Tuesday, January 29th. Finally, Credit Suisse Group began coverage on shares of Colgate-Palmolive in a research report on Wednesday, March 6th. They set an “underperform” rating on the stock. Three equities research analysts have rated the stock with a sell rating, twelve have issued a hold rating and four have given a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average price target of $65.73.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.
See Also: Closed-End Mutual Funds
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.